Wan Tai Biotech (603392.SH): The nine-valent human papillomavirus vaccine (colon E. coli) has obtained its first batch of approval certificates.

Zhtng CijngAPP News, Wantai Biology (603392.SH) announced recently that the nine-valent human papillomavirus vaccine (E. coli) produced by its wholly-owned subsidiary Xiamen Wantai Canghai Biological Technology Co., Ltd. (hereinafter referred to as "nine-valent HPV vaccine") has obtained the "Biological Product Batch Release Certificate" issued by the China Food and Drug Inspection Research Institute.